| Variables . | Case numbera . | Hazard ratios (95% CI)b . | P-value . |
|---|---|---|---|
| Univariate analysis | |||
| Gender (male vs. female) | 67/39 | 0.88 (0.58–1.34) | 0.558 |
| Age (>57.1 vs. ≤57.1) | 51/55 | 1.74 (1.16–2.63) | 0.008 |
| Tumor size (>5 vs. ≤5) | 55/51 | 1.77 (1.17–2.67) | 0.007 |
| Grade of differentiation (Grade 3 vs. Grade 1/2) | 53/52 | 1.50 (0.99–2.27) | 0.053 |
| TNM (I/II vs. III/IV) | 73/30 | 2.93 (1.78–4.83) | 0.000 |
| miR-7 (high vs. low) | 29/77 | 2.82 (1.70–4.67) | 0.000 |
| Multivariate analysis | |||
| Age (>57.1 vs. ≤57.1) | 51/55 | 1.73 (1.13–2.66) | 0.011 |
| Tumor Size (>5 vs. ≤5) | 55/51 | 1.07 (0.68–1.70) | 0.770 |
| Grade of differentiation (Grade 3 vs. Grade 1/2) | 53/52 | 1.32 (0.86–2.02) | 0.208 |
| TNM (I/II vs. III/IV) | 73/30 | 2.21 (1.26–3.89) | 0.006 |
| miR-7 (high vs. low) | 29/77 | 1.93 (1.15–3.24) | 0.014 |
| Variables . | Case numbera . | Hazard ratios (95% CI)b . | P-value . |
|---|---|---|---|
| Univariate analysis | |||
| Gender (male vs. female) | 67/39 | 0.88 (0.58–1.34) | 0.558 |
| Age (>57.1 vs. ≤57.1) | 51/55 | 1.74 (1.16–2.63) | 0.008 |
| Tumor size (>5 vs. ≤5) | 55/51 | 1.77 (1.17–2.67) | 0.007 |
| Grade of differentiation (Grade 3 vs. Grade 1/2) | 53/52 | 1.50 (0.99–2.27) | 0.053 |
| TNM (I/II vs. III/IV) | 73/30 | 2.93 (1.78–4.83) | 0.000 |
| miR-7 (high vs. low) | 29/77 | 2.82 (1.70–4.67) | 0.000 |
| Multivariate analysis | |||
| Age (>57.1 vs. ≤57.1) | 51/55 | 1.73 (1.13–2.66) | 0.011 |
| Tumor Size (>5 vs. ≤5) | 55/51 | 1.07 (0.68–1.70) | 0.770 |
| Grade of differentiation (Grade 3 vs. Grade 1/2) | 53/52 | 1.32 (0.86–2.02) | 0.208 |
| TNM (I/II vs. III/IV) | 73/30 | 2.21 (1.26–3.89) | 0.006 |
| miR-7 (high vs. low) | 29/77 | 1.93 (1.15–3.24) | 0.014 |